PriceTargets.com logo

CVS Health - CVS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $72.28
  • Forecasted Upside: 27.18%
  • Number of Analysts: 20
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$56.83 As of 11/20/2024 01:00 AM ET
▲ +1.06 (1.90%)

This chart shows the closing price for CVS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CVS Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

Analyst Price Target is $72.28
▲ +27.18% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $72.28, with a high forecast of $94.00 and a low forecast of $58.00. The average price target represents a 27.18% upside from the last price of $56.83.

This chart shows the closing price for CVS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 20 contributing investment analysts is to moderate buy stock in CVS Health. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 15 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 13 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 10 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 13 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/20/2024Truist FinancialReiterated RatingBuy ➝ Buy$76.00 ➝ $67.00
11/18/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$60.00 ➝ $66.00
11/15/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$68.00 ➝ $58.00
11/7/2024UBS GroupBoost TargetNeutral ➝ Neutral$60.00 ➝ $62.00
11/7/2024BarclaysLower TargetOverweight ➝ Overweight$75.00 ➝ $71.00
11/4/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$61.00 ➝ $60.00
10/24/2024MizuhoLower TargetOutperform ➝ Outperform$73.00 ➝ $66.00
10/23/2024BarclaysLower TargetOverweight ➝ Overweight$82.00 ➝ $75.00
10/11/2024Truist FinancialBoost TargetBuy ➝ Buy$66.00 ➝ $76.00
10/10/2024BarclaysUpgradeEqual Weight ➝ Overweight$63.00 ➝ $82.00
10/8/2024Evercore ISIBoost TargetOutperform ➝ Outperform$62.00 ➝ $75.00
10/4/2024TD CowenUpgradeHold ➝ Buy$59.00 ➝ $85.00
10/1/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$62.00 ➝ $62.00
9/16/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$62.00 ➝ $62.00
9/10/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$62.00 ➝ $62.00
9/4/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$68.00 ➝ $68.00
8/19/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$62.00 ➝ $62.00
8/12/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$60.00 ➝ $61.00
8/9/2024Deutsche Bank AktiengesellschaftLower TargetHold ➝ Hold$64.00 ➝ $63.00
8/8/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$65.00 ➝ $63.00
8/8/2024Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$58.00 ➝ $62.00
8/8/2024Evercore ISILower TargetOutperform ➝ Outperform$65.00 ➝ $62.00
7/23/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$58.00 ➝ $58.00
6/12/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$58.00 ➝ $58.00
5/30/2024Baird R WUpgradeHold
5/30/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$101.00 ➝ $86.00
5/30/2024Robert W. BairdInitiated CoverageNeutral$61.00
5/8/2024ArgusLower TargetBuy ➝ Buy$100.00 ➝ $80.00
5/7/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$76.00 ➝ $60.00
5/7/2024TD CowenDowngradeBuy ➝ Hold$99.00 ➝ $59.00
5/2/2024Bank of AmericaLower TargetBuy ➝ Buy$95.00 ➝ $77.00
5/2/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$85.00 ➝ $74.00
5/2/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$78.00 ➝ $63.00
5/2/2024Truist FinancialReiterated RatingBuy ➝ Buy$90.00 ➝ $66.00
5/2/2024MizuhoLower TargetBuy ➝ Buy$86.00 ➝ $72.00
5/2/2024UBS GroupDowngradeBuy ➝ Neutral$85.00 ➝ $60.00
5/1/2024Leerink PartnrsDowngradeOutperform ➝ Market Perform
5/1/2024Cantor FitzgeraldDowngradeOverweight ➝ Neutral$87.00 ➝ $58.00
5/1/2024Leerink PartnersReiterated RatingOutperform ➝ Market Perform$87.00 ➝ $60.00
4/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00
4/8/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$83.00 ➝ $76.00
4/4/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00
3/15/2024Piper SandlerBoost TargetOverweight ➝ Overweight$93.00 ➝ $94.00
3/6/2024BarclaysInitiated CoverageEqual Weight$78.00
2/26/2024Leerink PartnrsReiterated RatingOutperform
2/26/2024Leerink PartnersInitiated CoverageOutperform$88.00
2/8/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00
2/8/2024Royal Bank of CanadaLower TargetOutperform ➝ Outperform$86.00 ➝ $84.00
12/22/2023HSBCInitiated CoverageBuy$94.00
12/11/2023TD CowenLower TargetOutperform ➝ Outperform$102.00 ➝ $99.00
11/21/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00
11/2/2023Morgan StanleyLower TargetOverweight ➝ Overweight$110.00 ➝ $100.00
11/2/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$91.00 ➝ $86.00
10/10/2023Sanford C. BernsteinLower Target$93.00 ➝ $80.00
9/19/2023Evercore ISIUpgradeIn-Line ➝ Outperform$81.00 ➝ $83.00
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$87.00
9/12/2023Wolfe ResearchUpgradePeer Perform ➝ Outperform$80.00
9/1/2023Piper SandlerLower TargetOverweight ➝ Overweight$85.00 ➝ $82.00
8/18/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$91.00
8/17/2023Edward JonesDowngradeBuy ➝ Hold
8/4/2023Raymond JamesLower TargetOutperform ➝ Outperform$90.00 ➝ $85.00
8/3/2023Morgan StanleyLower TargetOverweight ➝ Overweight$120.00 ➝ $110.00
8/3/2023Royal Bank of CanadaLower TargetOutperform ➝ Outperform$102.00 ➝ $91.00
8/3/2023Truist FinancialLower TargetBuy ➝ Buy$103.00 ➝ $98.00
8/3/2023BarclaysLower TargetOverweight ➝ Overweight$89.00 ➝ $86.00
7/12/2023BarclaysLower Target$90.00 ➝ $89.00
7/11/2023MizuhoLower Target$120.00 ➝ $88.00
7/7/2023JPMorgan Chase & Co.Lower Target$114.00 ➝ $106.00
6/20/2023Truist FinancialLower Target$109.00 ➝ $103.00
5/30/2023JPMorgan Chase & Co.Lower Target$125.00 ➝ $114.00
5/25/2023Piper SandlerInitiated CoverageOverweight$85.00
5/8/2023Wells Fargo & CompanyLower Target$95.00 ➝ $76.00
5/8/2023Credit Suisse GroupLower Target$125.00 ➝ $96.00
5/4/2023Truist FinancialLower Target$115.00 ➝ $109.00
5/4/2023BarclaysLower Target$100.00 ➝ $90.00
5/2/2023UBS GroupLower Target$102.00 ➝ $94.00
5/2/2023Sanford C. BernsteinLower Target$107.00 ➝ $93.00
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$87.00
4/10/2023Deutsche Bank AktiengesellschaftInitiated CoverageHold
3/31/2023Bank of AmericaLower TargetBuy$111.00 ➝ $104.00
3/30/2023BarclaysLower TargetOverweight$110.00 ➝ $100.00
2/9/2023Royal Bank of CanadaReiterated RatingOutperform$115.00
2/9/2023Jefferies Financial GroupBoost TargetBuy$130.00 ➝ $143.00
2/9/2023Raymond JamesLower TargetOutperform$115.00 ➝ $110.00
2/9/2023BarclaysLower TargetOverweight$118.00 ➝ $110.00
1/13/2023Morgan StanleyBoost TargetOverweight$119.00 ➝ $120.00
1/3/2023Wells Fargo & CompanyLower TargetEqual Weight$106.00 ➝ $101.00
11/23/2022Morgan StanleyLower TargetOverweight$124.00 ➝ $119.00
11/21/2022Credit Suisse GroupBoost TargetOutperform$117.00 ➝ $125.00
11/8/2022Wells Fargo & CompanyLower TargetEqual Weight$111.00 ➝ $106.00
11/7/2022Royal Bank of CanadaLower TargetOutperform$119.00 ➝ $115.00
11/6/2022Raymond JamesLower Target$120.00 ➝ $115.00
11/3/2022JPMorgan Chase & Co.Lower TargetOverweight$130.00 ➝ $125.00
11/3/2022The Goldman Sachs GroupLower TargetBuy$128.00 ➝ $113.00
10/20/2022Bank of AmericaLower TargetBuy$122.00 ➝ $118.00
10/11/2022Morgan StanleyLower TargetOverweight$127.00 ➝ $124.00
9/7/2022Evercore ISIBoost TargetOutperform$120.00 ➝ $125.00
8/17/2022Tigress FinancialBoost Target$125.00 ➝ $130.00
8/15/2022MizuhoBoost TargetBuy$115.00 ➝ $120.00
8/8/2022Credit Suisse GroupBoost TargetOutperform$113.00 ➝ $117.00
8/4/2022UBS GroupBoost TargetBuy$118.00 ➝ $127.00
8/4/2022Deutsche Bank AktiengesellschaftBoost Target$113.00 ➝ $120.00
6/16/2022Loop CapitalInitiated CoverageBuy$120.00
5/26/2022Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$122.00 ➝ $112.00
5/5/2022Deutsche Bank AktiengesellschaftBoost Target$110.00 ➝ $113.00
4/7/2022Tigress FinancialBoost Target$122.00 ➝ $125.00
3/29/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$110.00
2/17/2022Deutsche Bank AktiengesellschaftBoost Target$107.00 ➝ $110.00
2/11/2022Raymond JamesDowngradeStrong-Buy ➝ Outperform$115.00 ➝ $120.00
2/10/2022BMO Capital MarketsBoost Target$108.00 ➝ $120.00
1/12/2022Robert W. BairdBoost Target$107.00 ➝ $110.00
1/11/2022Sanford C. BernsteinBoost Target$111.00 ➝ $116.00
1/10/2022Edward JonesUpgradeHold ➝ Buy
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$118.00 ➝ $124.00
12/23/2021Tigress FinancialBoost TargetBuy$108.00 ➝ $122.00
12/20/2021MizuhoBoost TargetBuy$110.00 ➝ $115.00
12/14/2021Robert W. BairdReiterated RatingHold
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$121.00
12/13/2021Morgan StanleyBoost TargetOverweight ➝ Overweight$115.00 ➝ $125.00
12/13/2021Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$98.00 ➝ $107.00
12/13/2021Robert W. BairdBoost TargetNeutral ➝ Neutral$100.00 ➝ $107.00
12/10/2021Truist FinancialBoost TargetBuy ➝ Buy$112.00 ➝ $118.00
12/10/2021CowenBoost TargetOutperform ➝ Outperform$103.00 ➝ $114.00
12/10/2021Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$107.00 ➝ $119.00
12/10/2021Credit Suisse GroupBoost TargetOutperform ➝ Outperform$107.00 ➝ $120.00
12/10/2021MizuhoBoost TargetBuy ➝ Buy$105.00 ➝ $110.00
12/6/2021Morgan StanleyBoost TargetOverweight$114.00 ➝ $115.00
12/1/2021Seaport Res PtnReiterated RatingBuy
11/10/2021MizuhoBoost TargetBuy$98.00 ➝ $105.00
11/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$101.00 ➝ $107.00
11/5/2021Credit Suisse GroupBoost TargetOutperform$100.00 ➝ $107.00
11/5/2021JPMorgan Chase & Co.Boost TargetBuy ➝ Overweight$107.00 ➝ $115.00
11/4/2021Truist FinancialBoost TargetBuy$94.00 ➝ $112.00
11/4/2021Royal Bank of CanadaBoost TargetOutperform$97.00 ➝ $107.00
11/4/2021Raymond JamesBoost TargetStrong-Buy$95.00 ➝ $115.00
11/4/2021CitigroupBoost TargetBuy$98.00 ➝ $111.00
11/4/2021BarclaysBoost TargetOverweight$100.00 ➝ $110.00
10/21/2021MizuhoReiterated RatingBuy
8/31/2021Morgan StanleyBoost TargetTop Pick ➝ Overweight$99.00 ➝ $114.00
8/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$95.00 ➝ $101.00
7/23/2021Tigress FinancialReiterated RatingBuy$108.00
6/22/2021Deutsche Bank AktiengesellschaftLower TargetBuy$99.00 ➝ $95.00
5/24/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00
5/19/2021BMO Capital MarketsBoost TargetPositive ➝ Market Perform$90.00 ➝ $96.00
5/19/2021BarclaysBoost TargetOverweight$92.00 ➝ $100.00
5/19/2021Wolfe ResearchBoost TargetPositive ➝ Outperform$82.00 ➝ $93.00
5/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$89.00
5/12/2021MizuhoBoost TargetPositive ➝ Buy$82.00 ➝ $98.00
5/6/2021Credit Suisse GroupBoost TargetOutperform$91.00 ➝ $100.00
5/6/2021BMO Capital MarketsBoost TargetMarket Perform$82.00 ➝ $90.00
5/5/2021CitigroupBoost Target$83.00 ➝ $98.00
5/5/2021Jefferies Financial GroupBoost TargetBuy$90.00 ➝ $95.00
5/5/2021Raymond JamesBoost TargetStrong-Buy$90.00 ➝ $95.00
5/5/2021Royal Bank of CanadaBoost TargetOutperform$80.00 ➝ $91.00
4/14/2021Truist FinancialBoost TargetBuy$80.00 ➝ $88.00
4/14/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $92.00
3/23/2021GuggenheimReiterated RatingBuy ➝ Neutral
3/17/2021GuggenheimDowngradeBuy ➝ Neutral
1/8/2021Jefferies Financial GroupUpgradeHold ➝ Buy$90.00
12/14/2020Leerink PartnersBoost TargetMarket Perform$73.00 ➝ $80.00
11/11/2020Piper SandlerBoost TargetOverweight$72.00 ➝ $76.00
11/9/2020Cantor FitzgeraldReiterated RatingOverweight
11/9/2020Deutsche Bank AktiengesellschaftLower TargetBuy$104.00 ➝ $101.00
9/17/2020Piper SandlerInitiated CoverageOverweight$72.00 ➝ $72.00
8/7/2020Credit Suisse GroupBoost TargetOutperform$75.00 ➝ $90.00
8/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$109.00 ➝ $104.00
8/6/2020Leerink PartnersBoost TargetMarket Perform$72.00 ➝ $73.00
7/9/2020Royal Bank of CanadaReiterated RatingBuy
7/1/2020Leerink PartnersInitiated CoverageMarket Perform$72.00
5/14/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$75.00
5/8/2020Credit Suisse GroupReiterated RatingHold
5/7/2020Robert W. BairdBoost TargetNeutral$62.00 ➝ $66.00
5/7/2020UBS GroupLower TargetBuy$85.00 ➝ $79.00
5/7/2020CitigroupLower TargetBuy$86.00 ➝ $75.00
5/7/2020Morgan StanleyBoost TargetOverweight$71.00 ➝ $77.00
5/6/2020Royal Bank of CanadaReiterated RatingBuy$77.00
5/6/2020OppenheimerReiterated RatingHold
5/4/2020JPMorgan Chase & Co.Lower TargetOverweight$97.00 ➝ $94.00
4/24/2020Tigress FinancialReiterated RatingBuy
4/13/2020Morgan StanleyBoost TargetOverweight$70.00 ➝ $71.00
4/13/2020SunTrust BanksLower TargetBuy$90.00 ➝ $80.00
4/12/2020Royal Bank of CanadaReiterated RatingBuy$77.00
3/27/2020Morgan StanleyLower TargetOverweight$88.00 ➝ $70.00
3/27/2020Robert W. BairdLower TargetNeutral$73.00 ➝ $62.00
3/25/2020Royal Bank of CanadaLower Target$85.00 ➝ $81.00
3/19/2020Credit Suisse GroupReiterated RatingHold$75.00
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$97.00 ➝ $109.00
2/14/2020CitigroupBoost TargetBuy$83.00 ➝ $86.00
2/13/2020Robert W. BairdBoost TargetNeutral$70.00 ➝ $73.00
2/13/2020UBS GroupBoost TargetBuy$78.00 ➝ $85.00
2/13/2020Cantor FitzgeraldBoost TargetOverweight$85.00 ➝ $90.00
2/12/2020OppenheimerInitiated CoverageHold
2/12/2020CfraBoost TargetStrong-Buy$85.00 ➝ $86.00
12/19/2019JPMorgan Chase & Co.Boost TargetOverweight$88.00 ➝ $97.00
12/4/2019Raymond JamesReiterated RatingStrong-Buy$80.00 ➝ $90.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.82 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 43 very positive mentions
  • 35 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024
  • 67 very positive mentions
  • 70 positive mentions
  • 30 negative mentions
  • 5 very negative mentions
Mentions as of
5/25/2024
  • 45 very positive mentions
  • 29 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 32 very positive mentions
  • 44 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 43 very positive mentions
  • 106 positive mentions
  • 17 negative mentions
  • 2 very negative mentions
Mentions as of
8/23/2024
  • 41 very positive mentions
  • 68 positive mentions
  • 9 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 50 very positive mentions
  • 53 positive mentions
  • 32 negative mentions
  • 4 very negative mentions
Mentions as of
10/22/2024
  • 79 very positive mentions
  • 60 positive mentions
  • 18 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 79 very positive mentions
  • 60 positive mentions
  • 18 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

CVS Health logo
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
Read More

Today's Range

Now: $56.83
Low: $56.00
High: $57.67

50 Day Range

MA: $59.18
Low: $53.19
High: $67.46

52 Week Range

Now: $56.83
Low: $52.71
High: $83.25

Volume

11,334,702 shs

Average Volume

11,378,567 shs

Market Capitalization

$71.52 billion

P/E Ratio

14.42

Dividend Yield

5.00%

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: Argus, Baird R W, Bank of America Co., Barclays PLC, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Evercore ISI, HSBC Holdings plc, JPMorgan Chase & Co., Leerink Partners, Leerink Partnrs, Mizuho, Piper Sandler, Robert W. Baird, Royal Bank of Canada, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for CVS.

What is the current price target for CVS Health?

0 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $72.28, suggesting a possible upside of 27.2%. HSBC Holdings plc has the highest price target set, predicting CVS will reach $94.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $58.00 for CVS Health in the next year.
View the latest price targets for CVS.

What is the current consensus analyst rating for CVS Health?

CVS Health currently has 7 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CVS.

What other companies compete with CVS Health?

Other companies that are similar to CVS Health include Walgreens Boots Alliance, Guardian Pharmacy Services, PetMed Express, 111 and China Jo-Jo Drugstores. Learn More about companies similar to CVS Health.

How do I contact CVS Health's investor relations team?

CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is (401) 765-1500 and its investor relations email address is [email protected]. The official website for CVS Health is www.cvshealth.com. Learn More about contacing CVS Health investor relations.